Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

US Patent 7855215 · Granted Dec 21, 2010

Estimated economic value: $11,671,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Pyrazolyl derivatives useful as anti-cancer agents2023
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2020
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors2019
Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinosi2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2019
Pharmaceutical combinations2018
Compounds2018
Use of inhibitors of the activity or function of PI3K2018
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL12018